Mind Medicine Mindmed Inc (NQ: MNMD )
3.550 +0.010 (+0.28%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 1, 2023 Add to My Watchlist
All News about Mind Medicine Mindmed Inc
MindMed to Participate at Upcoming Investor Conferences
Today 7:00 EDT
From Mind Medicine
Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study Australian psychedelics company MindBio Therapeutics Corp. was granted approval by both the Ethics...
Mind Medicine: Q1 Earnings Insights
May 04, 2023
Earnings Outlook For Mind Medicine
May 03, 2023
Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History NY-based biotech platform Terran Biosciences announced the publication of an international PCT patent application...
Clinical-stage biopharma company Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) has reported its unaudited financial results for the quarter ended March 31, 2023, and shared the period’s business...
April Psychedelic Drug Stocks Recap: The Ups And Downs
April 30, 2023
Via Talk Markets
MindMed to Participate in May Investor Conferences
April 26, 2023
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
April 24, 2023
LSD Trial Study Shows Potential For Major Depression Psychedelics biopharma company Mind Medicine Inc. (NASDAQ: MNMD) recently shared positive topline data from an advanced clinical trial of LSD as a...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following